Loading...
Loading...
Sterne Agee is out with its report today on Rubicon Technology
RBCN, lowering its PT to $7.
In its report, Sterne Agee writes, "We are not lowering our estimates, but given that our 2012 EPS estimate of $0.67 is well below consensus of $1.25 and our view that fundamentals will likely get worse before they get better, we believe a new, lower target price is warranted. Using a 10X multiple (down from our previous multiple of 15X) on our 2012 EPS estimate of $0.67 implies a $7 target."
At the time of posting, shares of RBCN were trading at $9.58, up 0.22% from Tuesday's close.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in